Robert N. Fried, CEO of Niagen Bioscience NAGE, has filed 1 purchase and 0 sales on the open market. The latest trade was on 04/24.

RF

RF

Robert N. Fried

CEO

Company

Niagen Bioscience NAGE

First filing

23/02/17

Trades

10 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

04/24

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Niagen BioscienceNAGE	Open-market buy	23/05/31	23/06/01	7,000 sh	$1.42	$9,940	+8.0%